EGFR and prostate carcinoma: One disease that closely approximates the lineage transitions observed in prostate cancer is EGFR- or ALK-mutant lung adenocarcinoma, where NE transition is a mechanism of escape from EGFR or ALK inhibition7,8,11,58,59.